期刊文献+

丙泊酚-氯诺昔康镇痛对清宫术后子宫收缩痛的影响 被引量:1

Effect of propofol with lornoxicam on postoperative pain of dilatation and curettage
下载PDF
导出
摘要 目的评价丙泊酚-氯诺昔康减轻清宫术后子宫收缩痛的效果。方法 90例ASAⅠ或Ⅱ级清宫手术患者随机分为研究组(45例)和对照组(45例)。研究组先缓慢静脉注射氯诺昔康8mg,10min后静脉注射丙泊酚2mg.kg-1;对照组先缓慢静脉注射芬太尼1μg.kg-1,10min后静脉注射丙泊酚2mg.kg-1。记录起效时间、苏醒时间、自行离床时间和丙泊酚总量,观察两组呼吸循环参数变化,采用VAS评分法评定术后镇痛效果。结果研究组患者苏醒即刻、苏醒后15min及30min宫缩痛的VAS评分均明显低于对照组,差异有统计学意义(P<0.05);研究组患者用药后2min和术后即刻SpO2均明显高于对照组,差异有统计学意义(P<0.05)。结论丙泊酚-氯诺昔康能有效减轻清宫术后的子宫收缩痛,值得临床推广应用。 OBJECTIVE To evaluate the effect of propofol with lornoxicam on reducing the postoperative pain of dilatation and curettage.METHODS 90 patients with ASA Ⅰor Ⅱ undergoing dilatation and curettage were randomly divided into study group(45 cases) and control group(45 cases).The study group was administrated intravenously lornoxicam 8mg followed by propofol 2mg·kg-1 10 minutes later,while the control group was administrated intravenously fentanyl 1μg·kg-1 followed by propofol 2mg·kg-1 10 minutes later.Record onset time,wake time,away from the bed on their own time and the total amount of propofol,observe the change of respiratory and circulatory parameters and assess the analgesic effect by VAS scores.RESULTS The VAS scores of study group at wake up instantly,and awakens in 15 min and 30 min after were significantly lower than the control group,the difference was statistically significant(P0.05);the SpO2 of study group 2min and immediately after treatment were significantly higher than control group,the difference was statistically significant(P0.05).CONCLUSION Propofol-lornoxicam can effectively reduce the postoperative pain of dilatation and curettage,it is worthy to be popularized.
作者 李晓虎
出处 《海峡药学》 2010年第6期119-121,共3页 Strait Pharmaceutical Journal
关键词 丙泊酚 氯诺昔康 子宫收缩痛 Propofol Lornoxicam Uterine contraction pain
  • 相关文献

参考文献3

二级参考文献34

  • 1段砺瑕,李晓玲.氟比洛芬酯注射液的药理作用及临床应用[J].中国新药杂志,2004,13(9):851-852. 被引量:602
  • 2张燕,赵延华,何振洲,王祥瑞.氟比洛芬酯用于术后自控静脉镇痛[J].临床麻醉学杂志,2007,23(6):475-477. 被引量:40
  • 3Ochroch EA, Mardini IA, Gott schalk A. What is the role of SAIDs in pre-emptive analgesia? Drugs, 2003,63:2709-2723.
  • 4Carmona L,Ballina J,Gabriel R,Laffon A.The burden of musculoskeletal diseases in the general population of Spain:results from a national survey.Ann Rheum Dis 2001; 60:1040-1045.
  • 5Wilcox CM,Allison J,Benzuly K,Borum M,Cryer B,Grosser T,Hunt R,Ladabaum U,Lanas A,Paulus H,Regueiro C,Sandler RS,Simon L.Consensus development conference on the use of nonsteroidal anti-inflammatory agents,including cyclooxygenase-2 enzyme inhibitors and aspirin.Clin Gastroenterol Hepatol 2006; 4:1082-1089.
  • 6European Medicines Agency.European Medicines Agency review concludes positive benefit-risk balance for nonselective NSAIDs.London,24 October 2006.Available from:URL:http://www.emea.europa.eu/pdfs/human/press/pr/41313606.pdf.
  • 7October 2006.Available from:URL:http://www.emea.europa.eu/pdfs/human/press/pr/41313606.pdf 4 COX-2 Selective and Non-Selective Non-Steroidal Anti-Inflammatory Drugs NSAIDs.Available from:URL:http://www.fda.gov/cder/drug/infopage/COX2/NSAIDRxTemplate.pdf.
  • 8Arora G,Singh G,Triadafilopoulos G.Proton pump inhibitors for gastroduodenal damage related to nonsteroidal anti-inflammatory drugs or aspirin:twelve important questions for clinical practice.Clin Gastroenterol Hepatol 2009; 7:725-735.
  • 9Sturkenboom MC,Burke TA,Dieleman JP,Tangelder MJ,Lee F,Goldstein JL.Underutilization of preventive strategies in patients receiving NSAIDs.Rheumatology (Oxford) 2003; 42Suppl 3:iii23-iii31.
  • 10Smalley W,Stein CM,Arbogast PG,Eisen G,Ray WA,Griffin M.Underutilization of gastroprotective measures in patients receiving nonsteroidal antiinflammatory drugs.Arthritis Rheum 2002; 46:2195-2200.

共引文献29

同被引文献5

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部